Aberdeen Royal Infirmary, Aberdeen, UK
Mon 14 11:50
HDI1.4
How do I use TRAb measurement to guide managment in my patients with Graves'?
Aberdeen Royal Infirmary, Aberdeen, UK
The Christie NHS Foundation Trust, Manchester, UK
Mon 14 11:05
HDI1.1
How do I manage hyponatraemia on the oncology ward, not just SAIDH ….?
The Christie NHS Foundation Trust, Manchester, UK
Imperial College NHS Healthcare Trust, London, UK
Wed 16 12:13
OP5.2
Hyperparathyroidism Jaw Tumour Syndrome Due to a Novel Familial CDC73 Germline Mutation
Imperial College NHS Healthcare Trust, London, UK
London, UK
Mon 14 14:30
PL2
University of Birmingham, Birmingham, UK
Tue 15 15:40
OC5.3
Normothermic Machine Liver Perfusion as a tool to study human androgen metabolism
University of Birmingham, Birmingham, UK
Afe Babalola University, Ado-Ekiti, Nigeria
Tue 15 13:21
OP3.3
Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3/ PROKR1 immunoreactivity
Afe Babalola University, Ado-Ekiti, Nigeria
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Tue 15 16:15
NS2.4
Endocrinopathies in Patients with Multiple Sclerosis
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Wellcome Trust–MRC Institute of Metabolic Science Metabolic Research Laboratories, Addenbrooke’s Hospital, Cambridge, UK
Tue 15 16:25
OC5.6
Labelling and Characterisation of Somatostatin Secreting D-Cells in Primary Human Duodenal Organoids Culture
Wellcome Trust–MRC Institute of Metabolic Science Metabolic Research Laboratories, Addenbrooke’s Hospital, Cambridge, UK
University of East Anglia, Norwich, UK
Wed 16 12:05
OP5.1
3’ UTR structural elements are associated with CYP24A1-mediated abnormal calcium handling
University of East Anglia, Norwich, UK
Imperial College London, London, UK
Tue 15 13:40
OP4.1
The effects of a tripeptide hormonal infusion on sweet taste function and eating behaviour
Imperial College London, London, UK
Montreal, Canada
Imperial College London, London, UK
Wed 16 10:35
S4.1
Size matters. Small molecule targeting of gonadotrophin hormone receptors
Imperial College London, London, UK
University of Birmingham, Birmingham, UK
Mon 14 12:53
OP1.2
Long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: EGRET study
Unknown speaker
University of Birmingham, Birmingham, UK
Tue 15 08:00
Investigating the Thyroid Nodule : A BTA/BAETS/SFE Joint Consensus Statement
University of Birmingham, Birmingham, UK
Tue 15 11:00
OCP1.1
What Endocrinology has Taught and Given Me
University of Birmingham, Birmingham, UK
University of Exeter, Exeter, UK
Medical University of Bialystok, Bialystok, Poland
Mon 14 13:09
OP1.4
The role of oxidative stress in differentiated thyroid cancer risk stratification
Medical University of Bialystok, Bialystok, Poland
Skåne University Hospital, Malmö, Sweden
Wed 16 15:50
CMW2.3
Non surgical therapies for aggressive pituitary tumours
Skåne University Hospital, Malmö, Sweden
Stockholm University, Stockholm, Sweden
Katholieke Universiteit Leuven, Leuven, Belgium
Wed 16 09:00
PL8
Skeletal cell metabolism: more than bioenergetics and bystander effect.
Katholieke Universiteit Leuven, Leuven, Belgium
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 14 10:20
EN2.1
Malignant PPGL
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 15 14:20
MTE3
Molecular imaging in PPGL
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 16 12:48
OP6.2
Investigating the utility of microRNA signatures as a tumour biomarker in patients with succinate dehydrogenase deficient phaeochromocytoma, paraganglioma and GIST
Unknown speaker
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Queen Mary University of London, London, UK
University of Cambridge, Cambridge, UK
Mon 14 16:05
OC2.5
Plasma metabolites correlate with disease in sdhx deficient cancer syndromes
University of Cambridge, Cambridge, UK
Queen Elizabeth University Hospital, Glasgow, UK
Mon 14 15:35
OC1.3
X-linked osteoporosis caused by a novel c.892-2A>G plastin 3 (PLS3) splice variant
Queen Elizabeth University Hospital, Glasgow, UK
University Hospitals Birmingham, Birmingham, UK
Mon 14 10:30
EN3.2
Survey on growth hormone discontinuation practice in the UK
University Hospitals Birmingham, Birmingham, UK
Sydney, Australia
John Radcliffe Hospital, Oxford, UK
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Wed 16 09:35
SK1.1
Parathyroid imaging
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
University of Oxford, Oxford, UK
Tue 15 16:10
OC5.5
Upregulation of hepatic de novo lipogenesis dissociates from changes in liver fat content and insulin sensitivity in healthy humans
University of Oxford, Oxford, UK
University of Edinburgh, Edinburgh, UK
Tue 15 15:40
OC4.3
Plasma steroid concentrations reflect disease severity during acute illness but not recovery after hospitalisation with COVID-19
University of Edinburgh, Edinburgh, UK
University of Duisburg-Essen, North Rhine-Westphalia, Germany
Wed 16 08:30
PL7
TED/GO from bench to bedside
University of Duisburg-Essen, North Rhine-Westphalia, Germany
Manchester Metropolitan University, Manchester, UK
Mon 14 11:05
BPW1.1
Exercise for beginners: new insights into key mechanisms and molecules
Manchester Metropolitan University, Manchester, UK
Moorfields Eye Hospital NHS Foundation Trust, London, UK
Imperial College London, London, UK
Tue 15 15:55
OC5.4
New avenues for vertical sleeve gastrectomy-induced diabetes remission mechanisms: kidney-adipose tissue axis
Imperial College London, London, UK
Oregon Health and Science University, Oregon, USA
Mon 14 14:00
PL1
Novel Approaches for Cushing’s Medical Management: Guidelines to Clinical Practice
Oregon Health and Science University, Oregon, USA
Imperial College London, London, UK
Wed 16 12:40
OP6.1
Post-Transcriptional Regulation of Wild-Type and Variant Androgen Receptors During Prostate Cancer Progression
Imperial College London, London, UK
Institution of Health Care Science Faculty of Medicine Lund University, Lund, Sweden
Tue 15 14:40
MTE2
New insights into Late Effects
Institution of Health Care Science Faculty of Medicine Lund University, Lund, Sweden
University of Leeds, Leeds, UK
University of Aberdeen, Aberdeen, UK
Helmholtz Zentrum München, Munich, Germany
Tue 15 17:10
BPW2.1
How does the brain know what you've eaten?
Helmholtz Zentrum München, Munich, Germany
University of Edinburgh, Edinburgh, UK
Mon 14 10:15
EN4.1
The year in thyroidology – Overview of the key papers from the last 12 months
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.2
Current hot topics affecting thyroid practice
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.3
Thyroid collaboration projects – join in collaborations and even form new ones
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
University of Edinburgh, Edinburgh, UK
Queen Mary University of London, London, UK
Mon 14 13:20
OP2.1
Novel radiolabeled ligand, Para-chloro-2-[18F]fluoroethyletomidate (CETO) compared to [11C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)
Queen Mary University of London, London, UK
Mon 14 13:36
OP2.3
Complete clinical cure of Primary Aldosteronism (PA) is predictable and sustained for at least two years
Queen Mary University of London, London, UK
Kings College Hospital foundation trust, London, UK
Austin, USA
Wed 16 15:50
CE1.3
University of Birmingham, Birmingham, UK
Mon 14 15:35
OC2.3
Identification of five prolactin receptor variants with diverse effects on receptor signalling
University of Birmingham, Birmingham, UK
Wed 16 14:10
EN6.1
Endocrine Network Session – Bone & Calcium
University of Birmingham, Birmingham, UK
Green Templeton College, University of Oxford, London, UK
Mon 14 10:40
EN3.4
My Most Challenging Pituitary Case
Unknown speaker
Green Templeton College, University of Oxford, London, UK
Royal Victoria Infirmary, Newcastle, UK
Mon 14 13:01
OP1.3
Levothyroxine Absorption Test: a therapeutic strategy for improving medication adherence
Royal Victoria Infirmary, Newcastle, UK
University of Oxford, Oxford, UK
Mon 14 15:20
OC1.1
Hypercalcaemic mice harbouring a germline ablation of G-protein subunit alpha-11 have anaemia that is corrected by treatment with erythropoietin
Unknown speaker
University of Oxford, Oxford, UK
The National Hospital for Neurology and Neurosurgery, UK
Mayo Clinic, Rochester, USA
Royal Free, UK
University of Michigan, Michigan, United States
Wed 16 11:05
S5.2
Are we overtreating low risk thyroid cancer
University of Michigan, Michigan, United States
University of Birmingham, Birmingham, UK
Tue 15 18:20
NS3.3
Weight Management following treatment of Craniopharyngiomas
University of Birmingham, Birmingham, UK
University of Birmingham, Birmingham, UK
Tue 15 16:25
OC4.6
Glucocorticoid Excess Elevates Metabolic Rate via a 11β-HSD1 Dependent Mechanism in C57BL/6J Mice
University of Birmingham, Birmingham, UK
The Netherlands
University of Birmingham, Birmingham, UK
Mon 14 18:15
D1.1
The Christie NHS Foundation Trust, Manchester, UK
Mon 14 10:17
EN3.1
UK Acromegaly Register: Past, Present and Future
The Christie NHS Foundation Trust, Manchester, UK
Imperial College London, London, UK
Tue 15 10:25
EC1.4
CET Best Basic Abstract: Characterising the G-protein signalling mechanisms activated by short chain fatty acids in human enteroendocrine cells which mediate production and release of the anorectic gut hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)
Imperial College London, London, UK
University of Nottingham, Nottingham, UK
Wed 16 15:00
ECS1.1
Best of both worlds: Bridging academic and industrial research
University of Nottingham, Nottingham, UK
University of Bristol, Bristol, UK
John Radcliffe Hospital, Oxford, UK
Tue 15 16:10
OC6.5
Thyroid hormones promote mammary metabolic pathways required for milk synthesis: Relevance to the onset of lactation
John Radcliffe Hospital, Oxford, UK
University of Groningen, Netherlands
Wed 16 15:25
CE1.2
Thermoregulation and photoperiodism in warm winters: Hibernators vs. non-hibernators
University of Groningen, Netherlands
The Pituitary Foundation, Bristol, UK
University of Sydney, Sydney, Australia
Mon 14 15:50
OC1.4
Measurements of circulating conjugated and unconjugated vitamin D metabolites by enzyme hydrolysis combined with liquid chromatography mass spectrometry
University of Sydney, Sydney, Australia
King's College London, London, UK
Wed 16 11:35
S4.3
Towards understanding the role of gonadotrophin receptor oligomerisation in reproductive health and disease
King's College London, London, UK
Nottingham Trent University, Nottingham, UK
Tue 15 13:56
OP4.3
miR-10b is an essential regulator of adipogenesis.
Nottingham Trent University, Nottingham, UK
Birmingham, UK
Mon 14 10:55
EN3.5
King's College London, London, UK
Tue 15 15:25
OC4.2
Generation of novel tools for the study and development of targeted therapeutic approaches for pheochromocytoma and paraganglioma.
King's College London, London, UK
University of Birmingham, Birmingham, UK
Tue 15 11:00
TAA1
SIMBA and CoMICs – developing evidence based, minimal cost, and sustainable medical education programmes
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Mon 14 12:45
OP1.1
The ‘real-world’ outcomes of immunosuppression for Graves’ orbitopathy (GO) in a single centre multi-ethnic cohort.
Imperial College London, London, UK
Acting Chief of Thyroid Tumours and Functional Thyroid Disorders, Metabolic Disease Branch, National Institutes of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, USA
Tue 15 12:30
S3.3
Drug repurposing in endocrine cancer
Acting Chief of Thyroid Tumours and Functional Thyroid Disorders, Metabolic Disease Branch, National Institutes of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, USA
University of Birmingham, Birmingham, UK
Wed 16 12:56
OP6.3
Knockout mouse embryonic fibroblasts reveal a physiological role for the proto-oncogene PBF in cell adhesion and motility.
University of Birmingham, Birmingham, UK
University of Oxford, Oxford, UK
Mon 14 16:20
OC1.6
The AXT914 calcilytic compound increases plasma calcium and PTH in a mouse model for autosomal dominant hypocalcaemia type 1 (ADH1)
University of Oxford, Oxford, UK
Erasmus University Medical Center, Netherlands, Netherlands
Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK
Mon 14 15:05
OC3.1
Depot somatostatin receptor ligand therapy reverses tissue thyrotoxicosis in thyrotropinomas and aids microadenoma localization via 11C-Methionine PET
Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
University College London Hospitals NHS Foundation Trust, London, UK
Wed 16 12:29
OP5.4
Prospective clinical trial of a novel, reusable, pocket size Point of Care device to measure ionized calcium in venous and capillary blood and saliva.
Unknown speaker
University College London Hospitals NHS Foundation Trust, London, UK
Newcastle University, Newcastle, UK
Tue 15 16:25
OC6.6
Can systemic cytokines predict relapse of Graves’ disease?
Newcastle University, Newcastle, UK
University of Oxford, Oxford, UK
University of London and University College London Hospitals NHS Foundation Trust, London, UK
Tue 15 11:00
NKM1
Integrating Nursing, Behavioural Science and Digital Health to Promote Self-management
University of London and University College London Hospitals NHS Foundation Trust, London, UK
Wed 16 15:15
ECS1.2
A Clinical Academic Career Pathway in Endocrinology Nursing
University of London and University College London Hospitals NHS Foundation Trust, London, UK
University of Manchester, Manchester, UK
University of Oxford, Oxford, UK
Tue 15 09:55
EC1.2
Early Career Prize Lecture Clinical: Central adiposity raises serum calcium concentrations and increases risk of kidney stone disease
University of Oxford, Oxford, UK
Institute of Veterinary Physiology, Zurich, Switzerland
Tue 15 11:30
S2.1
Therapeutic potential of an old friend (Amylin)
Institute of Veterinary Physiology, Zurich, Switzerland
St James’s Hospital, Leeds, UK
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Mon 14 15:05
OC3.1
Depot somatostatin receptor ligand therapy reverses tissue thyrotoxicosis in thyrotropinomas and aids microadenoma localization via 11C-Methionine PET
Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Mon 14 16:05
OC3.5
Radiomics as a tool for risk stratification of non-functioning pituitary adenomas following primary surgery
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
University of Birmingham, Birmingham, UK
Mon 14 15:20
OC2.2
Promotion of Thyroid Cancer Cell Migration and Invasion by the Proto-Oncogene PBF is Mediated by FGD1 and N-WASP
University of Birmingham, Birmingham, UK
National Hospital for Neurology and Neurosurgery, London, UK
Wed 16 15:25
CMW2.2
Novel surgical approaches to pituitary disease
National Hospital for Neurology and Neurosurgery, London, UK
Queen Mary University of London, London, UK
Mon 14 13:44
OP2.4
Delta-like non-canonical Notch ligand 1 (DLK1)-expressing adrenocortical progenitor cells: role in adrenal turnover, remodeling and tumorigenesis in mice.
Queen Mary University of London, London, UK
Imperial College London, London, UK
Tue 15 13:15
The Biomedical Kitchen: Demystifying the Laboratory for Students
Imperial College London, London, UK
Wellcome Sanger Institute, Cambridge, UK
Tue 15 15:10
OC6.1
Single cell analysis for the human developing thyroid uncovers thyrocytes heterogeneity
Wellcome Sanger Institute, Cambridge, UK
Genetech, USA, USA
Imperial College London, London, UK
Tue 15 17:10
HDI2.1
Outstanding Clinical Practitioner Award 2: How do I wean patients who have had pituitary or adrenal Cushings syndrome off glucocorticoids once they are in remission?
Imperial College London, London, UK
Tue 15 17:25
HDI2.1
How do I rationalise withdrawal of liothyronine (T3) in a symptomatic tired, depressed and vulnerable patient with chronic fatigue syndrome or long COVID who may or may not have hypothyroidism?
Imperial College London, London, UK
University of Edinburgh Medical School, Edinburgh, UK
Mon 14 09:40
WIN1
What is New in Basic Endocrinology Research?
University of Edinburgh Medical School, Edinburgh, UK
The Francis Crick Institute, London, UK
Wed 16 13:20
MTE7
How to study sex: new approaches for investigating sex determinant pathways
The Francis Crick Institute, London, UK
School of Biomolecular Sciences at University of Glasgow, Glasgow, Scotland
Tue 15 12:30
S2.3
Can we drug receptors for microbially-produced metabolic hormones?
School of Biomolecular Sciences at University of Glasgow, Glasgow, Scotland
Imperial College London, London, UK
Tue 15 13:05
OP3.1
Kisspeptin Enhances Penile Tumescence and Sexual Brain Processing in Men with Low Sexual Desire
Unknown speaker
Imperial College London, London, UK
Imperial College London, London, UK
Tue 15 13:48
OP4.2
Differential effects of L- and D-lactate on HCAR1 signalling
Imperial College London, London, UK
Spire Manchester Hospital, Manchester, UK
Mon 14 11:35
HDI1.3
How do I answer the common difficult questions from patients with hypothyroidism?
Spire Manchester Hospital, Manchester, UK
Cambridge University, Cambridge, UK
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 16 14:20
EN7.2
Incidence of endocrine deficits after management of brain tumours
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Imperial College London, London, UK
Wed 16 13:04
OP6.4
Endocrinopathies in cancer patients receiving immune checkpoint inhibitors are associated with an improved overall survival
Imperial College London, London, UK
Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Tue 15 14:20
MTE5.1
Building back bones after cancer therapy (prov) Adults
Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Ninewells Hospital and University of Dundee, Dundee, UK
Mon 14 15:05
OC2.1
Generation of conditional MEN1 knockout human induced pluripotent stem cells (iPSCs) provide a genetically-tractable disease model to investigate cell-type specific gene function
Ninewells Hospital and University of Dundee, Dundee, UK
DefiniGEN Ltd., Cambridge, UK
Tue 15 14:04
OP4.4
iPSC-derived hepatocytes as a novel tool for Glycogen Storage Disease 1A (GSD1A) modelling and drug screening.
DefiniGEN Ltd., Cambridge, UK
University of Oxford, Oxford, UK
Tue 15 15:25
OC5.2
7α-hydroxy-3-oxo-4-cholestenoic acid (7-HOCA) is a novel AKR1D1 substrate driving metabolic dysfunction and hepatocellular cancer risk in patients with non-alcoholic fatty liver disease (NAFLD).
University of Oxford, Oxford, UK
Oxford, United Kingdom
King's College London, London, UK
Tue 15 17:40
BPW2.2
New methods to investigate the GnRH pulse generator
King's College London, London, UK
University of Cambridge, Cambridge, UK
Beaumont Hospital, Dublin, Ireland
Tue 15 17:40
HDI2.2
How do I choose an oral contraceptive for my PCOS patient?
Beaumont Hospital, Dublin, Ireland
University Hospital of Wales, Cardiff, UK
Tue 15 15:10
OC4.1
Introducing technology to improve patient safety in adrenal insufficiency: a proof-of-concept delivery of a new smartphone app in steroid-dependent patients.
University Hospital of Wales, Cardiff, UK
Newcastle University, Newcastle, UK
Tue 15 07:45
Use of Liothyronine: joint British Thyroid Association and Society for Endocrinology Consensus Statement
Newcastle University, Newcastle, UK
Wed 16 16:50
PL10
Why don’t we cure all patients with Graves’ disease?
Newcastle University, Newcastle, UK
Barts and The London School of Medicine and Dentistry, London, UK
Mon 14 15:50
OC2.4
Delta-like non-canonical Notch ligand 1 (DLK1) – a novel biomarker in adrenocortical carcinoma
Barts and The London School of Medicine and Dentistry, London, UK
Oxford, United Kingdom
Mon 14 13:28
OP2.2
Can serum and urine Fludrocortisone measurements guide mineralocorticoid replacement therapy in primary adrenal insufficiency?
Oxford, United Kingdom
University of Cambridge, Cambridge, UK
Wed 16 13:20
MTE6
Imaging of Bone for Endocrinologists; from DXA onwards
University of Cambridge, Cambridge, UK
Royal Devon and Exeter Hospital and University of Exeter Medical School, Devon and Exeter, UK
Tue 15 17:55
HDI2.3
How do I manage a patent with menopausal symptoms in whom HRT is contra-indicated?
Royal Devon and Exeter Hospital and University of Exeter Medical School, Devon and Exeter, UK
University of Birmingham, Birmingham, UK
Tue 15 15:55
OC4.4
Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk
Unknown speaker
University of Birmingham, Birmingham, UK
Wed 16 11:35
S6.3
New applications of steroid metabolomics to adrenal tumours
University of Birmingham, Birmingham, UK
University of Leeds, Leeds, UK
Queen Mary University of London, London, UK
Tue 15 13:13
OP3.2
Identification of differentially activated pathways in recurrent non-functioning pituitary tumours using quantitative proteomics and bioinformatics analysis
Queen Mary University of London, London, UK
University Hospitals Coventry, Coventry, UK
Mon 14 15:35
OC3.3
Long-term efficacy and safety of oral, once-daily paltusotine treatment in acromegaly: Two-year interim results from the ACROBAT Advance study
University Hospitals Coventry, Coventry, UK
Department of Medicine III – Bone Lab, Medical Faculty of the Technische Universität Dresden, Dresden, Germany
Tue 15 12:30
S1.3
Skeletal fragility and diabetes
Department of Medicine III – Bone Lab, Medical Faculty of the Technische Universität Dresden, Dresden, Germany
University of Birmingham, Birmingham, UK
Mon 14 16:20
OC2.6
Repurposing disulfiram as a therapeutic agent to enhance sodium iodide symporter activity in radioiodide therapy
University of Birmingham, Birmingham, UK
University Hospitals of Leicester NHS Trust, Leicester, UK
Wed 16 15:30
ECS1.3
Incorporating Research Into Clinical Activity
University Hospitals of Leicester NHS Trust, Leicester, UK
Cardiff University, United Kingdom
Mon 14 09:55
WIN2
Tue 15 16:10
OC4.5
Comparison of prednisolone and modified-release hydrocortisone capsules in the treatment of congenital adrenal hyperplasia: dose and disease control
Unknown speaker
Cardiff University, United Kingdom
Bournemouth University, Poole, UK
Tue 15 15:55
OC6.4
Towards an automated app-based dose prescription of carbimazole for hyperthyroidism patients
Bournemouth University, Poole, UK
Leighton Hospital, Cheshire, UK
Wed 16 09:35
Implementation of DFE recommendations
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Mid Cheshire Hospitals NHS Foundation Trust
Wed 16 09:35
Implementation of DFE recommendations
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
University of Birmingham, Birmingham, United Kingdom
Mon 14 12:05
HDI1.5
How do I monitor a patient on mitotane?
Unknown speaker
University of Birmingham, Birmingham, United Kingdom
Maine Medical Center, Maine, USA
London
Glasgow, UK
University of Texas Southwestern Medical Center, Texas, United States
Tue 15 18:45
PL6
Adipose Tissue Organ Crosstalk in Health and Disease
University of Texas Southwestern Medical Center, Texas, United States
University of Sheffield/ Sheffield Teaching Hospitals, Sheffield, UK
Mon 14 12:20
HDI1.6
How do I manage normocalcaemic hyperparathyroidism?
University of Sheffield/ Sheffield Teaching Hospitals, Sheffield, UK
University Hospital Birmingham, Birmingham, UK
Aruvant Sciences, Millburn, USA
Mon 14 15:05
OC1.1
Evaluation of efficacy and safety of a novel gene therapy drug (ARU-2801) for hypophosphatasia in non-human primates
Aruvant Sciences, Millburn, USA
University of Birmingham, Birmingham, UK
Tue 15 14:20
MTE1
Interventions for Preventing Adrenal Crisis
University of Birmingham, Birmingham, UK
Royal College of Surgeons in Ireland, Dublin, Ireland
Wed 16 14:10
EN5.1
Management of iatrogenic adrenal insufficiency – tip of the iceberg
Unknown speaker
Royal College of Surgeons in Ireland, Dublin, Ireland
University College London Hospital, London, UK
Wed 16 14:30
EN7.3
A multidisciplinary approach to managing patients with brain tumours
University College London Hospital, London, UK
Ohio State University, Columbous, Ohio
Wed 16 10:35
S5.1
What is new in diagnosing thyroid malignancy
Ohio State University, Columbous, Ohio
Random 42- scientific communication, London, UK
Wed 16 15:45
ECS1.4
Writing about research for a living-graphic design for pharmaceuticals
Random 42- scientific communication, London, UK
University Hospital Dresden, Dresden, Germany
Wed 16 10:35
S6.1
Stem cell therapy in adrenal insufficiency
University Hospital Dresden, Dresden, Germany
The University of Edinburgh, Edinburgh, UK
Tue 15 09:35
EC1.1
Early Career Prize Lecture Basic Science: The diverse and distinct roles of adipose tissue on metabolic heath
The University of Edinburgh, Edinburgh, UK
University of Edinburgh, Edinburgh, UK
Tue 15 15:10
OC5.1
Human brown adipose tissue demonstrates substantial choline uptake for incorporation into phosphatidylcholines.
University of Edinburgh, Edinburgh, UK
Oxford Radcliffe Hospital, Oxford, UK
Tue 15 12:00
NS1.2
The Role of the Nurse in Addressing the Needs of Patients with Neuroendocrine Cancer
Oxford Radcliffe Hospital, Oxford, UK
Imperial College London, London, United Kingdom
Mon 14 10:20
EN1.1
Update on Metabolic & Obesity Network hypoglycaemia-post bariatric surgery guidelines
Imperial College London, London, United Kingdom
Mon 14 11:20
HDI1.2
How do I diagnose and manage non-diabetic postprandial hypoglycaemia?
Imperial College London, London, United Kingdom
University of East Anglia, Norwich, UK
Wed 16 12:21
OP5.3
Lower bone mineral density is associated with primary hyperparathyroidism patients with abnormal vitamin D metabolite ratio (VMR): A case-control study
University of East Anglia, Norwich, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.1
The year in thyroidology – Overview of the key papers from the last 12 months
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.2
Current hot topics affecting thyroid practice
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.3
Thyroid collaboration projects – join in collaborations and even form new ones
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Tue 15 10:15
EC1.3
CET Best Clinical Abstract: Individuals on levothyroxine have higher HADS anxiety and depression scores than the general population and this is exacerbated by the Thr92Ala substitution in DIO2.
Unknown speaker
Cardiff University, Cardiff, UK
Oxford, United Kingdom
Imperial College London, London, UK
Mon 14 16:20
OC3.6
Kisspeptin enhances sexual and attraction brain processing in women with low sexual desire
Imperial College London, London, UK
University of Oxford, Oxford, UK
Birmingham, UK
King's College London, London, UK
Tue 15 13:29
OP3.4
Identification and characterisation of novel follicle-stimulating hormone receptor antagonists
King's College London, London, UK
NYU Center for the Investigation of Environmental Hazards, New York, USA
Wed 16 15:00
CE1.1
Endocrine Disrupting Chemicals: New Knowledge of Health Effects and Policy Implications
NYU Center for the Investigation of Environmental Hazards, New York, USA
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 15 15:10
NS2.1
Endocrine effects of checkpoint inhibitor immunotherapy
Oxford University Hospitals NHS Trust, Oxford, UK
Norfolk and Norwich University Hospital, Norfolk, UK
Tue 15 18:10
HDI2.4
How do I investigate hypophosphataemia?
Norfolk and Norwich University Hospital, Norfolk, UK
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Tue 15 14:40
MTE5.2
Building back bones after cancer therapy (prov) Paeds
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Weston Park Cancer Centre, Sheffield, United Kingdom
Wed 16 11:35
S5.3
Novel target therapies for advanced thyroid cancer
Weston Park Cancer Centre, Sheffield, United Kingdom
Department of Internal Medicine IV, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
Tue 15 11:30
S3.1
Pre clinical and clinical evaluation of targeted therapies in PPGL
Department of Internal Medicine IV, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
Nuffield Health Oxford Hospital, Oxford, United Kingdom
Wed 16 09:45
Overview of the GiRFT recommendations
Nuffield Health Oxford Hospital, Oxford, United Kingdom
Germany
Guy’s & St Thomas Hospitals, London, UK
Tue 15 18:25
HDI2.5
How do I manage severe hypertriglyceridaemia?
Guy’s & St Thomas Hospitals, London, UK
University College London Hospitals NHS Foundation Trust, London, UK
Mon 14 16:05
OC1.5
Can pre-operative treatment with intravenous bisphosphonates or cinacalcet have an effect on intra-operative parathyroid hormone measurements?
University College London Hospitals NHS Foundation Trust, London, UK
King’s College London, London, UK
Mon 14 15:20
OC3.2
BRF1-mediated paracrine signalling from pituitary stem cells is required for terminal differentiation of pituitary committed progenitors
King’s College London, London, UK
Cambridge University, Cambridge, UK
Mon 14 17:00
Antibodies and antibody mimics as pharmaceutical drugs
Cambridge University, Cambridge, UK
University Hospital of Copenhagen, Copenhagen, Denmark
Wed 16 11:05
S4.2
Regulation of human oocyte maturation: interaction of gonadotropins and somatic cells of the follicle.
University Hospital of Copenhagen, Copenhagen, Denmark
University of Cambridge, Cambridge, UK
Wed 16 16:20
Mapping the Brain Feeding Circuitry Using Single Cell Approaches
University of Cambridge, Cambridge, UK
Mount Sinai Professor of Clinical Medicine, Director, Center for Translational Medicine and Pharmacology, Icahn Sinai School of Medicine at Mount Sinai, New York, USA
Tue 15 11:30
S1.1
Pituitary Hormones, Bone, Belly and Brain
Mount Sinai Professor of Clinical Medicine, Director, Center for Translational Medicine and Pharmacology, Icahn Sinai School of Medicine at Mount Sinai, New York, USA
University of Birmingham, Birmingham, UK
Tue 15 15:25
OC6.2
Enhancing Radioiodide Uptake by Addressing the Mechanism of Sodium/Iodide Symporter (NIS) Endocytosis
University of Birmingham, Birmingham, UK
Workshop
4
Oral
12
Expert
7
Plenary
11
Catering and Social
10
Nurse
3
Other
4
Symposium
5
No Session Type
33
Mon 14 11:05
BPW1.1
Exercise for beginners: new insights into key mechanisms and molecules
Manchester Metropolitan University, Manchester, UK
Tue 15 17:10
BPW2.1
How does the brain know what you've eaten?
Helmholtz Zentrum München, Munich, Germany
Tue 15 17:40
BPW2.2
New methods to investigate the GnRH pulse generator
King's College London, London, UK
Wed 16 09:35
Implementation of DFE recommendations
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 16 09:45
Overview of the GiRFT recommendations
Nuffield Health Oxford Hospital, Oxford, United Kingdom
Wed 16 15:25
CMW2.2
Novel surgical approaches to pituitary disease
National Hospital for Neurology and Neurosurgery, London, UK
Wed 16 15:50
CMW2.3
Non surgical therapies for aggressive pituitary tumours
Skåne University Hospital, Malmö, Sweden
Mon 14 12:45
OP1.1
The ‘real-world’ outcomes of immunosuppression for Graves’ orbitopathy (GO) in a single centre multi-ethnic cohort.
Imperial College London, London, UK
Mon 14 12:53
OP1.2
Long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: EGRET study
Unknown speaker
University of Birmingham, Birmingham, UK
Mon 14 13:01
OP1.3
Levothyroxine Absorption Test: a therapeutic strategy for improving medication adherence
Royal Victoria Infirmary, Newcastle, UK
Mon 14 13:09
OP1.4
The role of oxidative stress in differentiated thyroid cancer risk stratification
Medical University of Bialystok, Bialystok, Poland
Mon 14 13:20
OP2.1
Novel radiolabeled ligand, Para-chloro-2-[18F]fluoroethyletomidate (CETO) compared to [11C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)
Queen Mary University of London, London, UK
Mon 14 13:28
OP2.2
Can serum and urine Fludrocortisone measurements guide mineralocorticoid replacement therapy in primary adrenal insufficiency?
Oxford, United Kingdom
Mon 14 13:36
OP2.3
Complete clinical cure of Primary Aldosteronism (PA) is predictable and sustained for at least two years
Queen Mary University of London, London, UK
Mon 14 13:44
OP2.4
Delta-like non-canonical Notch ligand 1 (DLK1)-expressing adrenocortical progenitor cells: role in adrenal turnover, remodeling and tumorigenesis in mice.
Queen Mary University of London, London, UK
Mon 14 15:05
OC1.1
Evaluation of efficacy and safety of a novel gene therapy drug (ARU-2801) for hypophosphatasia in non-human primates
Aruvant Sciences, Millburn, USA
Mon 14 15:20
OC1.1
Hypercalcaemic mice harbouring a germline ablation of G-protein subunit alpha-11 have anaemia that is corrected by treatment with erythropoietin
Unknown speaker
University of Oxford, Oxford, UK
Mon 14 15:35
OC1.3
X-linked osteoporosis caused by a novel c.892-2A>G plastin 3 (PLS3) splice variant
Queen Elizabeth University Hospital, Glasgow, UK
Mon 14 15:50
OC1.4
Measurements of circulating conjugated and unconjugated vitamin D metabolites by enzyme hydrolysis combined with liquid chromatography mass spectrometry
University of Sydney, Sydney, Australia
Mon 14 16:05
OC1.5
Can pre-operative treatment with intravenous bisphosphonates or cinacalcet have an effect on intra-operative parathyroid hormone measurements?
University College London Hospitals NHS Foundation Trust, London, UK
Mon 14 16:20
OC1.6
The AXT914 calcilytic compound increases plasma calcium and PTH in a mouse model for autosomal dominant hypocalcaemia type 1 (ADH1)
University of Oxford, Oxford, UK
Mon 14 15:05
OC2.1
Generation of conditional MEN1 knockout human induced pluripotent stem cells (iPSCs) provide a genetically-tractable disease model to investigate cell-type specific gene function
Ninewells Hospital and University of Dundee, Dundee, UK
Mon 14 15:20
OC2.2
Promotion of Thyroid Cancer Cell Migration and Invasion by the Proto-Oncogene PBF is Mediated by FGD1 and N-WASP
University of Birmingham, Birmingham, UK
Mon 14 15:35
OC2.3
Identification of five prolactin receptor variants with diverse effects on receptor signalling
University of Birmingham, Birmingham, UK
Mon 14 15:50
OC2.4
Delta-like non-canonical Notch ligand 1 (DLK1) – a novel biomarker in adrenocortical carcinoma
Barts and The London School of Medicine and Dentistry, London, UK
Mon 14 16:05
OC2.5
Plasma metabolites correlate with disease in sdhx deficient cancer syndromes
University of Cambridge, Cambridge, UK
Mon 14 16:20
OC2.6
Repurposing disulfiram as a therapeutic agent to enhance sodium iodide symporter activity in radioiodide therapy
University of Birmingham, Birmingham, UK
Mon 14 15:05
OC3.1
Depot somatostatin receptor ligand therapy reverses tissue thyrotoxicosis in thyrotropinomas and aids microadenoma localization via 11C-Methionine PET
Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Mon 14 15:20
OC3.2
BRF1-mediated paracrine signalling from pituitary stem cells is required for terminal differentiation of pituitary committed progenitors
King’s College London, London, UK
Mon 14 15:35
OC3.3
Long-term efficacy and safety of oral, once-daily paltusotine treatment in acromegaly: Two-year interim results from the ACROBAT Advance study
University Hospitals Coventry, Coventry, UK
Mon 14 16:05
OC3.5
Radiomics as a tool for risk stratification of non-functioning pituitary adenomas following primary surgery
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Mon 14 16:20
OC3.6
Kisspeptin enhances sexual and attraction brain processing in women with low sexual desire
Imperial College London, London, UK
Tue 15 13:05
OP3.1
Kisspeptin Enhances Penile Tumescence and Sexual Brain Processing in Men with Low Sexual Desire
Unknown speaker
Imperial College London, London, UK
Tue 15 13:13
OP3.2
Identification of differentially activated pathways in recurrent non-functioning pituitary tumours using quantitative proteomics and bioinformatics analysis
Queen Mary University of London, London, UK
Tue 15 13:21
OP3.3
Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3/ PROKR1 immunoreactivity
Afe Babalola University, Ado-Ekiti, Nigeria
Tue 15 13:29
OP3.4
Identification and characterisation of novel follicle-stimulating hormone receptor antagonists
King's College London, London, UK
Tue 15 13:40
OP4.1
The effects of a tripeptide hormonal infusion on sweet taste function and eating behaviour
Imperial College London, London, UK
Tue 15 13:48
OP4.2
Differential effects of L- and D-lactate on HCAR1 signalling
Imperial College London, London, UK
Tue 15 13:56
OP4.3
miR-10b is an essential regulator of adipogenesis.
Nottingham Trent University, Nottingham, UK
Tue 15 14:04
OP4.4
iPSC-derived hepatocytes as a novel tool for Glycogen Storage Disease 1A (GSD1A) modelling and drug screening.
DefiniGEN Ltd., Cambridge, UK
Tue 15 15:10
OC4.1
Introducing technology to improve patient safety in adrenal insufficiency: a proof-of-concept delivery of a new smartphone app in steroid-dependent patients.
University Hospital of Wales, Cardiff, UK
Tue 15 15:25
OC4.2
Generation of novel tools for the study and development of targeted therapeutic approaches for pheochromocytoma and paraganglioma.
King's College London, London, UK
Tue 15 15:40
OC4.3
Plasma steroid concentrations reflect disease severity during acute illness but not recovery after hospitalisation with COVID-19
University of Edinburgh, Edinburgh, UK
Tue 15 15:55
OC4.4
Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk
Unknown speaker
University of Birmingham, Birmingham, UK
Tue 15 16:10
OC4.5
Comparison of prednisolone and modified-release hydrocortisone capsules in the treatment of congenital adrenal hyperplasia: dose and disease control
Unknown speaker
Cardiff University, United Kingdom
Tue 15 16:25
OC4.6
Glucocorticoid Excess Elevates Metabolic Rate via a 11β-HSD1 Dependent Mechanism in C57BL/6J Mice
University of Birmingham, Birmingham, UK
Tue 15 15:10
OC5.1
Human brown adipose tissue demonstrates substantial choline uptake for incorporation into phosphatidylcholines.
University of Edinburgh, Edinburgh, UK
Tue 15 15:25
OC5.2
7α-hydroxy-3-oxo-4-cholestenoic acid (7-HOCA) is a novel AKR1D1 substrate driving metabolic dysfunction and hepatocellular cancer risk in patients with non-alcoholic fatty liver disease (NAFLD).
University of Oxford, Oxford, UK
Tue 15 15:40
OC5.3
Normothermic Machine Liver Perfusion as a tool to study human androgen metabolism
University of Birmingham, Birmingham, UK
Tue 15 15:55
OC5.4
New avenues for vertical sleeve gastrectomy-induced diabetes remission mechanisms: kidney-adipose tissue axis
Imperial College London, London, UK
Tue 15 16:10
OC5.5
Upregulation of hepatic de novo lipogenesis dissociates from changes in liver fat content and insulin sensitivity in healthy humans
University of Oxford, Oxford, UK
Tue 15 16:25
OC5.6
Labelling and Characterisation of Somatostatin Secreting D-Cells in Primary Human Duodenal Organoids Culture
Wellcome Trust–MRC Institute of Metabolic Science Metabolic Research Laboratories, Addenbrooke’s Hospital, Cambridge, UK
Tue 15 15:10
OC6.1
Single cell analysis for the human developing thyroid uncovers thyrocytes heterogeneity
Wellcome Sanger Institute, Cambridge, UK
Tue 15 15:25
OC6.2
Enhancing Radioiodide Uptake by Addressing the Mechanism of Sodium/Iodide Symporter (NIS) Endocytosis
University of Birmingham, Birmingham, UK
Tue 15 15:55
OC6.4
Towards an automated app-based dose prescription of carbimazole for hyperthyroidism patients
Bournemouth University, Poole, UK
Tue 15 16:10
OC6.5
Thyroid hormones promote mammary metabolic pathways required for milk synthesis: Relevance to the onset of lactation
John Radcliffe Hospital, Oxford, UK
Tue 15 16:25
OC6.6
Can systemic cytokines predict relapse of Graves’ disease?
Newcastle University, Newcastle, UK
Wed 16 12:05
OP5.1
3’ UTR structural elements are associated with CYP24A1-mediated abnormal calcium handling
University of East Anglia, Norwich, UK
Wed 16 12:13
OP5.2
Hyperparathyroidism Jaw Tumour Syndrome Due to a Novel Familial CDC73 Germline Mutation
Imperial College NHS Healthcare Trust, London, UK
Wed 16 12:21
OP5.3
Lower bone mineral density is associated with primary hyperparathyroidism patients with abnormal vitamin D metabolite ratio (VMR): A case-control study
University of East Anglia, Norwich, UK
Wed 16 12:29
OP5.4
Prospective clinical trial of a novel, reusable, pocket size Point of Care device to measure ionized calcium in venous and capillary blood and saliva.
Unknown speaker
University College London Hospitals NHS Foundation Trust, London, UK
Wed 16 12:40
OP6.1
Post-Transcriptional Regulation of Wild-Type and Variant Androgen Receptors During Prostate Cancer Progression
Imperial College London, London, UK
Wed 16 12:48
OP6.2
Investigating the utility of microRNA signatures as a tumour biomarker in patients with succinate dehydrogenase deficient phaeochromocytoma, paraganglioma and GIST
Unknown speaker
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 16 12:56
OP6.3
Knockout mouse embryonic fibroblasts reveal a physiological role for the proto-oncogene PBF in cell adhesion and motility.
University of Birmingham, Birmingham, UK
Wed 16 13:04
OP6.4
Endocrinopathies in cancer patients receiving immune checkpoint inhibitors are associated with an improved overall survival
Imperial College London, London, UK
Tue 15 14:20
MTE1
Interventions for Preventing Adrenal Crisis
University of Birmingham, Birmingham, UK
Tue 15 14:40
MTE2
New insights into Late Effects
Institution of Health Care Science Faculty of Medicine Lund University, Lund, Sweden
Tue 15 14:20
MTE3
Molecular imaging in PPGL
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 15 14:20
MTE5.1
Building back bones after cancer therapy (prov) Adults
Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Tue 15 14:40
MTE5.2
Building back bones after cancer therapy (prov) Paeds
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Wed 16 13:20
MTE6
Imaging of Bone for Endocrinologists; from DXA onwards
University of Cambridge, Cambridge, UK
Wed 16 13:20
MTE7
How to study sex: new approaches for investigating sex determinant pathways
The Francis Crick Institute, London, UK
Mon 14 10:20
EN1.1
Update on Metabolic & Obesity Network hypoglycaemia-post bariatric surgery guidelines
Imperial College London, London, United Kingdom
Mon 14 14:00
PL1
Novel Approaches for Cushing’s Medical Management: Guidelines to Clinical Practice
Oregon Health and Science University, Oregon, USA
Mon 14 14:30
PL2
Tue 15 18:45
PL6
Adipose Tissue Organ Crosstalk in Health and Disease
University of Texas Southwestern Medical Center, Texas, United States
Wed 16 08:30
PL7
TED/GO from bench to bedside
University of Duisburg-Essen, North Rhine-Westphalia, Germany
Wed 16 09:00
PL8
Skeletal cell metabolism: more than bioenergetics and bystander effect.
Katholieke Universiteit Leuven, Leuven, Belgium
Wed 16 16:20
Mapping the Brain Feeding Circuitry Using Single Cell Approaches
University of Cambridge, Cambridge, UK
Wed 16 16:50
PL10
Why don’t we cure all patients with Graves’ disease?
Newcastle University, Newcastle, UK
Tue 15 12:00
NS1.2
The Role of the Nurse in Addressing the Needs of Patients with Neuroendocrine Cancer
Oxford Radcliffe Hospital, Oxford, UK
Tue 15 15:10
NS2.1
Endocrine effects of checkpoint inhibitor immunotherapy
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 15 16:15
NS2.4
Endocrinopathies in Patients with Multiple Sclerosis
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Tue 15 18:20
NS3.3
Weight Management following treatment of Craniopharyngiomas
University of Birmingham, Birmingham, UK
Mon 14 11:05
HDI1.1
How do I manage hyponatraemia on the oncology ward, not just SAIDH ….?
The Christie NHS Foundation Trust, Manchester, UK
Mon 14 11:20
HDI1.2
How do I diagnose and manage non-diabetic postprandial hypoglycaemia?
Imperial College London, London, United Kingdom
Mon 14 11:35
HDI1.3
How do I answer the common difficult questions from patients with hypothyroidism?
Spire Manchester Hospital, Manchester, UK
Mon 14 11:50
HDI1.4
How do I use TRAb measurement to guide managment in my patients with Graves'?
Aberdeen Royal Infirmary, Aberdeen, UK
Mon 14 12:05
HDI1.5
How do I monitor a patient on mitotane?
Unknown speaker
University of Birmingham, Birmingham, United Kingdom
Mon 14 12:20
HDI1.6
How do I manage normocalcaemic hyperparathyroidism?
University of Sheffield/ Sheffield Teaching Hospitals, Sheffield, UK
Tue 15 13:15
The Biomedical Kitchen: Demystifying the Laboratory for Students
Imperial College London, London, UK
Tue 15 11:30
S2.1
Therapeutic potential of an old friend (Amylin)
Institute of Veterinary Physiology, Zurich, Switzerland
Tue 15 12:30
S2.3
Can we drug receptors for microbially-produced metabolic hormones?
School of Biomolecular Sciences at University of Glasgow, Glasgow, Scotland
Tue 15 11:30
S3.1
Pre clinical and clinical evaluation of targeted therapies in PPGL
Department of Internal Medicine IV, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
Tue 15 12:30
S3.3
Drug repurposing in endocrine cancer
Acting Chief of Thyroid Tumours and Functional Thyroid Disorders, Metabolic Disease Branch, National Institutes of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, USA
Wed 16 10:35
S4.1
Size matters. Small molecule targeting of gonadotrophin hormone receptors
Imperial College London, London, UK
Wed 16 11:05
S4.2
Regulation of human oocyte maturation: interaction of gonadotropins and somatic cells of the follicle.
University Hospital of Copenhagen, Copenhagen, Denmark
Wed 16 11:35
S4.3
Towards understanding the role of gonadotrophin receptor oligomerisation in reproductive health and disease
King's College London, London, UK
Wed 16 10:35
S5.1
What is new in diagnosing thyroid malignancy
Ohio State University, Columbous, Ohio
Wed 16 11:05
S5.2
Are we overtreating low risk thyroid cancer
University of Michigan, Michigan, United States
Wed 16 11:35
S5.3
Novel target therapies for advanced thyroid cancer
Weston Park Cancer Centre, Sheffield, United Kingdom
Wed 16 10:35
S6.1
Stem cell therapy in adrenal insufficiency
University Hospital Dresden, Dresden, Germany
Wed 16 11:35
S6.3
New applications of steroid metabolomics to adrenal tumours
University of Birmingham, Birmingham, UK
Mon 14 09:40
WIN1
What is New in Basic Endocrinology Research?
University of Edinburgh Medical School, Edinburgh, UK
Mon 14 09:55
WIN2
Mon 14 10:20
EN2.1
Malignant PPGL
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 14 10:17
EN3.1
UK Acromegaly Register: Past, Present and Future
The Christie NHS Foundation Trust, Manchester, UK
Mon 14 10:30
EN3.2
Survey on growth hormone discontinuation practice in the UK
University Hospitals Birmingham, Birmingham, UK
Mon 14 10:40
EN3.4
My Most Challenging Pituitary Case
Unknown speaker
Green Templeton College, University of Oxford, London, UK
Mon 14 10:55
EN3.5
Mon 14 10:15
EN4.1
The year in thyroidology – Overview of the key papers from the last 12 months
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.2
Current hot topics affecting thyroid practice
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 10:15
EN4.3
Thyroid collaboration projects – join in collaborations and even form new ones
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 14 17:00
Antibodies and antibody mimics as pharmaceutical drugs
Cambridge University, Cambridge, UK
Mon 14 18:15
D1.1
Tue 15 07:45
Use of Liothyronine: joint British Thyroid Association and Society for Endocrinology Consensus Statement
Newcastle University, Newcastle, UK
Tue 15 08:00
Investigating the Thyroid Nodule : A BTA/BAETS/SFE Joint Consensus Statement
University of Birmingham, Birmingham, UK
Tue 15 09:35
EC1.1
Early Career Prize Lecture Basic Science: The diverse and distinct roles of adipose tissue on metabolic heath
The University of Edinburgh, Edinburgh, UK
Tue 15 09:55
EC1.2
Early Career Prize Lecture Clinical: Central adiposity raises serum calcium concentrations and increases risk of kidney stone disease
University of Oxford, Oxford, UK
Tue 15 10:15
EC1.3
CET Best Clinical Abstract: Individuals on levothyroxine have higher HADS anxiety and depression scores than the general population and this is exacerbated by the Thr92Ala substitution in DIO2.
Unknown speaker
Cardiff University, Cardiff, UK
Tue 15 10:25
EC1.4
CET Best Basic Abstract: Characterising the G-protein signalling mechanisms activated by short chain fatty acids in human enteroendocrine cells which mediate production and release of the anorectic gut hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)
Imperial College London, London, UK
Tue 15 11:00
TAA1
SIMBA and CoMICs – developing evidence based, minimal cost, and sustainable medical education programmes
University of Birmingham, Birmingham, UK
Tue 15 11:00
OCP1.1
What Endocrinology has Taught and Given Me
University of Birmingham, Birmingham, UK
Tue 15 11:00
NKM1
Integrating Nursing, Behavioural Science and Digital Health to Promote Self-management
University of London and University College London Hospitals NHS Foundation Trust, London, UK
Tue 15 11:30
S1.1
Pituitary Hormones, Bone, Belly and Brain
Mount Sinai Professor of Clinical Medicine, Director, Center for Translational Medicine and Pharmacology, Icahn Sinai School of Medicine at Mount Sinai, New York, USA
Tue 15 12:30
S1.3
Skeletal fragility and diabetes
Department of Medicine III – Bone Lab, Medical Faculty of the Technische Universität Dresden, Dresden, Germany
Tue 15 17:10
HDI2.1
Outstanding Clinical Practitioner Award 2: How do I wean patients who have had pituitary or adrenal Cushings syndrome off glucocorticoids once they are in remission?
Imperial College London, London, UK
Tue 15 17:25
HDI2.1
How do I rationalise withdrawal of liothyronine (T3) in a symptomatic tired, depressed and vulnerable patient with chronic fatigue syndrome or long COVID who may or may not have hypothyroidism?
Imperial College London, London, UK
Tue 15 17:40
HDI2.2
How do I choose an oral contraceptive for my PCOS patient?
Beaumont Hospital, Dublin, Ireland
Tue 15 17:55
HDI2.3
How do I manage a patent with menopausal symptoms in whom HRT is contra-indicated?
Royal Devon and Exeter Hospital and University of Exeter Medical School, Devon and Exeter, UK
Tue 15 18:10
HDI2.4
How do I investigate hypophosphataemia?
Norfolk and Norwich University Hospital, Norfolk, UK
Tue 15 18:25
HDI2.5
How do I manage severe hypertriglyceridaemia?
Guy’s & St Thomas Hospitals, London, UK
Wed 16 09:35
SK1.1
Parathyroid imaging
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Wed 16 14:10
EN5.1
Management of iatrogenic adrenal insufficiency – tip of the iceberg
Unknown speaker
Royal College of Surgeons in Ireland, Dublin, Ireland
Wed 16 14:10
EN6.1
Endocrine Network Session – Bone & Calcium
University of Birmingham, Birmingham, UK
Wed 16 14:20
EN7.2
Incidence of endocrine deficits after management of brain tumours
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 16 14:30
EN7.3
A multidisciplinary approach to managing patients with brain tumours
University College London Hospital, London, UK
Wed 16 15:00
ECS1.1
Best of both worlds: Bridging academic and industrial research
University of Nottingham, Nottingham, UK
Wed 16 15:15
ECS1.2
A Clinical Academic Career Pathway in Endocrinology Nursing
University of London and University College London Hospitals NHS Foundation Trust, London, UK
Wed 16 15:30
ECS1.3
Incorporating Research Into Clinical Activity
University Hospitals of Leicester NHS Trust, Leicester, UK
Wed 16 15:45
ECS1.4
Writing about research for a living-graphic design for pharmaceuticals
Random 42- scientific communication, London, UK
Wed 16 15:00
CE1.1
Endocrine Disrupting Chemicals: New Knowledge of Health Effects and Policy Implications
NYU Center for the Investigation of Environmental Hazards, New York, USA
Wed 16 15:25
CE1.2
Thermoregulation and photoperiodism in warm winters: Hibernators vs. non-hibernators
University of Groningen, Netherlands
Wed 16 15:50
CE1.3
0 result(s) found.